T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Carlyle Group
CG
$17.6B
| $6.36M | ﹤0.01% |
+234,600
| New | +$6.24M |
|
|
TTM
1427
DELISTED
Tata Motors Limited
TTM
| $6.34M | ﹤0.01% |
140,749
-152,695
| -52% | -$7.2M |
|
1428
XPO
XPO
$24.8B
| $6.33M | ﹤0.01% |
402,329
-33,829
| -8% | -$490K |
|
1429
GameStop
GME
$8.41B
| $6.31M | ﹤0.01% |
665,040
-139,600
| -17% | -$1.31M |
|
|
PACW
1430
DELISTED
PacWest Bancorp
PACW
| $6.25M | ﹤0.01% |
133,385
-32,300
| -19% | -$1.46M |
|
1431
LKQ Corp
LKQ
$6.42B
| $6.17M | ﹤0.01% |
241,236
-20,225
| -8% | -$524K |
|
|
AIG.WS
1432
DELISTED
American International Group, Inc.
AIG.WS
| $6.15M | ﹤0.01% |
281,700
| – | – |
|
1433
Golar LNG
GLNG
$5.33B
| $6.15M | ﹤0.01% |
184,700
-12,552
| -6% | -$402K |
|
1434
Buckle
BKE
$2.27B
| $6.11M | ﹤0.01% |
119,562
-1,300
| -1% | -$65.5K |
|
1435
BHP
BHP
$220B
| $6.09M | ﹤0.01% |
155,046
+8,397
| +6% | +$341K |
|
1436
Stepan Co
SCL
$1.48B
| $6.07M | ﹤0.01% |
145,638
-18,200
| -11% | -$725K |
|
1437
ATI
ATI
$31B
| $6.04M | ﹤0.01% |
201,111
-273,882
| -58% | -$8.51M |
|
1438
Paylocity
PCTY
$7.9B
| $6.01M | ﹤0.01% |
209,700
| – | – |
|
|
FSYS
1439
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $6M | ﹤0.01% |
543,110
-600
| -0.1% | -$6.51K |
|
|
DISH
1440
DELISTED
DISH Network Corp.
DISH
| $5.97M | ﹤0.01% |
85,165
-7,475
| -8% | -$552K |
|
1441
lululemon athletica
LULU
$13.5B
| $5.89M | ﹤0.01% |
92,000
+1,000
| +1% | +$64.1K |
|
|
XENT
1442
DELISTED
Intersect ENT, Inc
XENT
| $5.85M | ﹤0.01% |
+226,416
| New | +$5.18M |
|
1443
Standex International
SXI
$3.99B
| $5.84M | ﹤0.01% |
71,100
+3,000
| +4% | +$222K |
|
|
LDRH
1444
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $5.82M | ﹤0.01% |
158,903
-62,452
| -28% | -$2.27M |
|
1445
Hyster-Yale Materials Handling
HY
$615M
| $5.8M | ﹤0.01% |
79,194
+1,200
| +2% | +$81.2K |
|
1446
IQVIA
IQV
$39.1B
| $5.77M | ﹤0.01% |
86,200
-5,900
| -6% | -$372K |
|
1447
OGE Energy
OGE
$9.81B
| $5.77M | ﹤0.01% |
182,578
+8,380
| +5% | +$281K |
|
|
CRRC
1448
DELISTED
COURIER CORP
CRRC
| $5.76M | ﹤0.01% |
235,279
-759,398
| -76% | -$16.6M |
|
|
QEP
1449
DELISTED
QEP RESOURCES, INC.
QEP
| $5.73M | ﹤0.01% |
275,020
+5,180
| +2% | +$108K |
|
|
INFO
1450
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $5.58M | ﹤0.01% |
207,300
-6,300
| -3% | -$166K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.